Your browser doesn't support javascript.
loading
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
Kim, Stefano; Buecher, Bruno; André, Thierry; Jary, Marine; Bidard, François-Clément; Ghiringhelli, François; François, Éric; Taieb, Julien; Smith, Denis; de la Fouchardière, Christelle; Desramé, Jérôme; Samalin, Emmanuelle; Parzy, Aurélie; Baba-Hamed, Nabil; Bouché, Olivier; Tougeron, David; Dahan, Laëtitia; El Hajbi, Farid; Jacquin, Marion; Rebucci-Peixoto, Magali; Spehner, Laurie; Vendrely, Véronique; Vernerey, Dewi; Borg, Christophe.
Afiliación
  • Kim S; Department of Oncology, University Hospital of Besançon, 3 Boulevard Alexander Flemingn, F-25030, Besançon, France. stefanokim@me.com.
  • Buecher B; Hôpital Nord Franche Comté, Montbéliard, France. stefanokim@me.com.
  • André T; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France. stefanokim@me.com.
  • Jary M; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France. stefanokim@me.com.
  • Bidard FC; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France. stefanokim@me.com.
  • Ghiringhelli F; Fédération Francophone de Cancérologie Digestive (FFCD), Paris, France. stefanokim@me.com.
  • François É; Institut Curie, Paris, France.
  • Taieb J; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France.
  • Smith D; Sorbonne Université and Hôpital Saint Antoine, Paris, France.
  • de la Fouchardière C; Department of Oncology, University Hospital of Besançon, 3 Boulevard Alexander Flemingn, F-25030, Besançon, France.
  • Desramé J; Hôpital Nord Franche Comté, Montbéliard, France.
  • Samalin E; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France.
  • Parzy A; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France.
  • Baba-Hamed N; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France.
  • Bouché O; Institut Curie, Paris, France.
  • Tougeron D; Centre Georges-François Leclerc, Dijon, France.
  • Dahan L; Centre Antoine-Lacassagne, Nice, France.
  • El Hajbi F; Hôpital Européen Georges-Pompidou, Paris, France.
  • Jacquin M; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Rebucci-Peixoto M; Centre Léon Bérard, Lyon, France.
  • Spehner L; Hôpital Privé Jean Mermoz, Lyon, France.
  • Vendrely V; Institut du Cancer de Montpellier, Montpellier, France.
  • Vernerey D; Centre François Baclesse, Caen, France.
  • Borg C; Groupe Hospitalier Paris Saint-Joseph, Paris, France.
BMC Cancer ; 20(1): 352, 2020 Apr 25.
Article en En | MEDLINE | ID: mdl-32334548
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Francia